Ilham Kandoussi

发表

Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis

J. E. Harti, Mohammed Hakmi, E. M. Bouricha, 2020, Bioinformation.

Virtual docking screening and QSAR studies to explore AKT and mTOR inhibitors acting on PI3K in cancers

A. Ibrahimi, Wiame Lakhlili, J. Taoufik, 2020, Contemporary oncology.

Phylogeography and genomic analysis of SARS-CoV-2 delta variant in Morocco.

L. Belyamani, A. Ibrahimi, Tarik Aanniz, 2022, Journal of infection in developing countries.

Docking analysis of verteporfin with YAP WW domain

A. Ibrahimi, Wiame Lakhlili, J. Taoufik, 2017, Bioinformation.

AKT1 Polymorphism (rs10138227) and Risk of Colorectal Cancer in Moroccan Population: A Case Control Study

H. Amri, A. Ibrahimi, M. A. Bendahou, 2020, Asian Pacific journal of cancer prevention : APJCP.

In Silico Analyses of All STAT3 Missense Variants Leading to Explore Divergent AD-HIES Clinical Phenotypes

L. Belyamani, Mohammed Hakmi, A. Ibrahimi, 2023, Evolutionary bioinformatics online.

Anthraquinones: A Promising Multi-target Therapeutic Scaffold To Treat Covid-19

L. Belyamani, Mohammed Hakmi, A. Ibrahimi, 2021 .

Virtual docking screening and quantitative structure-activity relationship studies to explore AKT and PI3K inhibitors acting on mTOR in cancers by theoretical biology and medical modeling

A. Ibrahimi, Ilham Kandoussi, Lahcen Belyamani, 2023, Contemporary oncology.

Targeting decaprenylphosphoryl-β-D-ribose 2′-epimerase for Innovative Drug Development Against Mycobacterium Tuberculosis Drug-Resistant Strains

A. Ibrahimi, Ilham Kandoussi, Lahcen Belyamani, 2024, Bioinformatics and biology insights.

Overcoming Resistance in Cancer Therapy: Computational Exploration of PIK3CA Mutations, Unveiling Novel Non-Toxic Inhibitors, and Molecular Insights Into Targeting PI3Kα

Ilham Kandoussi, Azeddine Ibrahimi, Lahcen Belyamani, 2024, Bioinformatics and biology insights.

Syk protein inhibitors treatment for the allergic symptoms associated with hyper immunoglobulin E syndromes: A focused on a computational approach.

Ilham Kandoussi, Azeddine Ibrahimi, Lahcen Belyamani, 2024, International journal of immunopathology and pharmacology.

Facing Antitubercular Resistance: Identification of Potential Direct Inhibitors Targeting InhA Enzyme and Generation of 3D-pharmacophore Model by in silico Approach

L. Belyamani, A. Ibrahimi, H. Bendani, 2023, Advances and applications in bioinformatics and chemistry : AABC.

Selective Non-toxics Inhibitors Targeting DHFR for Tuberculosis and Cancer Therapy: Pharmacophore Generation and Molecular Dynamics Simulation

L. Belyamani, A. Ibrahimi, M. W. Chemao-Elfihri, 2023, Bioinformatics and biology insights.